- Home
- IGMS vs ATSG Comparison
IGMS vs ATSG Comparison
Compare IGMS & ATSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGMS
- ATSG
- Stock Information
- Founded
- IGMS 1993
- ATSG 1980
- Country
- IGMS United States
- ATSG United States
- Employees
- IGMS N/A
- ATSG N/A
- Industry
- IGMS Biotechnology: Pharmaceutical Preparations
- ATSG Air Freight/Delivery Services
- Sector
- IGMS Health Care
- ATSG Consumer Discretionary
- Exchange
- IGMS Nasdaq
- ATSG Nasdaq
- Market Cap
- IGMS 962.1M
- ATSG 1.1B
- IPO Year
- IGMS 2019
- ATSG N/A
- Fundamental
- Price
- IGMS $9.47
- ATSG $22.02
- Analyst Decision
- IGMS Hold
- ATSG Buy
- Analyst Count
- IGMS 8
- ATSG 5
- Target Price
- IGMS $14.63
- ATSG $20.60
- AVG Volume (30 Days)
- IGMS 238.9K
- ATSG 1.8M
- Earning Date
- IGMS 11-08-2024
- ATSG 11-08-2024
- Dividend Yield
- IGMS N/A
- ATSG N/A
- EPS Growth
- IGMS N/A
- ATSG N/A
- EPS
- IGMS N/A
- ATSG N/A
- Revenue
- IGMS $2,918,000.00
- ATSG $1,962,220,000.00
- Revenue This Year
- IGMS $298.54
- ATSG N/A
- Revenue Next Year
- IGMS N/A
- ATSG $4.10
- P/E Ratio
- IGMS N/A
- ATSG N/A
- Revenue Growth
- IGMS 57.64
- ATSG N/A
- 52 Week Low
- IGMS $4.72
- ATSG $11.62
- 52 Week High
- IGMS $22.50
- ATSG $22.27
- Technical
- Relative Strength Index (RSI)
- IGMS 28.30
- ATSG 84.71
- Support Level
- IGMS $10.91
- ATSG $22.00
- Resistance Level
- IGMS $16.32
- ATSG $22.14
- Average True Range (ATR)
- IGMS 1.53
- ATSG 0.25
- MACD
- IGMS -0.79
- ATSG 0.18
- Stochastic Oscillator
- IGMS 0.80
- ATSG 95.31
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.
About ATSG Air Transport Services Group Inc
Air Transport Services Group Inc along with its subsidiaries operates within the airfreight and logistics industry. It leases aircraft and provides airline operations, ground services, aircraft modification and maintenance, and other support services mainly to the cargo transportation and package delivery industries. The company has two reportable segments namely Cargo Aircraft Management and ACMI Services (Aircraft, Crew, Maintenance, and Insurance). It generates a majority of its revenue from the ACMI services segment.